E
Eva Harris
Researcher at University of California, Berkeley
Publications - 357
Citations - 26475
Eva Harris is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Dengue virus & Dengue fever. The author has an hindex of 84, co-authored 332 publications receiving 22718 citations.
Papers
More filters
Journal ArticleDOI
In silico drug repurposing for the identification of potential candidate molecules against arboviruses infection.
Diana Montes-Grajales,Henry Puerta-Guardo,Diego A. Espinosa,Eva Harris,William Caicedo-Torres,Jesus Olivero-Verbel,Esperanza Martínez-Romero +6 more
TL;DR: The anti-asthmatic pranlukast is proposed as a drug candidate against DENV, ZikV, and CHIKV, supporting further in vitro and in vivo assessment of the potential of this and other lead compounds that exhibited good affinity scores in silico as therapeutic agents or scaffolds for the development of new drugs against arboviral diseases.
Journal ArticleDOI
Innovative low cost technologies for biomedical research and diagnosis in developing countries
Josefina Coloma,Eva Harris +1 more
TL;DR: Researchers in the developed world can learn much from the ingenuity and passion of colleagues in developing countries, as working in resource poor settings fosters creativity and a mindset for conservation and better management of resources.
Journal ArticleDOI
Prevalence and Clinical Profile of Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Farmworkers, California, USA, June-November 2020.
Joseph A Lewnard,Ana M. Mora,Oguchi Nkwocha,Katherine Kogut,Stephen Rauch,Norma Morga,Samantha Hernandez,Marcus P Wong,Karen Huen,Kristin L. Andrejko,Nicholas P. Jewell,Kimberly Parra,Nina Holland,Eva Harris,Maximiliano Cuevas,Brenda Eskenazi,CHAMACOS-Project Study Team +16 more
TL;DR: In this paper, the authors conducted prospective surveillance for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and antibody prevalence among farmworkers in Salinas Valley, California, during June 15-November 30, 2020.
Journal ArticleDOI
Influenza and dengue virus co-infection impairs monocyte recruitment to the lung, increases dengue virus titers, and exacerbates pneumonia
Michael A. Schmid,Karla Gonzalez,Sanjana Shah,José Peña,Matthias Mack,Laura B. Talarico,Fernando P. Polack,Eva Harris +7 more
TL;DR: This study shows that co‐infection with influenza and DENV impairs host responses, which fail to control DENV titers and instead, induce severe lung damage, and identifies key inflammatory pathways and monocyte function as targets for future therapies that may limit immunopathology in co‐ Infected patients.
Journal ArticleDOI
Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection
Antonio Gregorio Dias,C. Atyeo,Carolin Loos,Magelda Montoya,Vicky Roy,Sandra Bos,Parnal Narvekar,T. Singh,Leah C. Katzelnick,Guillermina Kuan,Douglas A. Lauffenburger,Angel Balmaseda,Galit Alter,Eva Harris +13 more
TL;DR: